Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06676488 · ClinicalTrials.gov registry record · NA

A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

A NA study of Irritable Bowel Syndrome (IBS) and Circadian Misalignment, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06676488 is a NA study of Irritable Bowel Syndrome (IBS) and Circadian Misalignment that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 30 participants, below the 1,183-participant average among 5 other Irritable Bowel Syndrome (IBS) trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06676488, a NA study of Irritable Bowel Syndrome (IBS) and Circadian Misalignment, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to assess whether morning bright light therapy (BLT) using a wearable device called a Re-Timer could potentially improve Irritable Bowel Syndrome (IBS) symptoms and decrease intestinal permeability (leaky gut). Morning bright light therapy will be administrated through a safe-wearable glasses device called a Re-Timer. The Re-Timer glasses are lightweight and deliver blue-green light at 500nm, mimicking exposure to natural light.

Interventions

  • DEVICE Re-Timer glasses
  • DEVICE Placebo Device

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-06-11
Est. Completion 2026-03-31
Phase NA

What the Registry Record Tells You About NCT06676488

The ClinicalTrials.gov registry entry for NCT06676488 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,183-participant average among 5 other Irritable Bowel Syndrome (IBS) trials with a reported enrollment target (97% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Irritable Bowel Syndrome (IBS) appearing as the primary indexed condition, and to 2 interventions - of which Re-Timer glasses is the first listed.

NCT06676488 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06676488 about?

NCT06676488 is a clinical study titled "A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome". The purpose of this research study is to assess whether morning bright light therapy (BLT) using a wearable device called a Re-Timer could potentially improve Irritable Bowel Syndrome (IBS) symptoms and decrease intestinal permeability (leaky gut). Morning bright light therapy will be administrated ...

What is the current status of trial NCT06676488?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-06-11. Estimated completion is 2026-03-31.

What conditions does trial NCT06676488 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome (IBS), Circadian Misalignment.

What interventions are being tested in trial NCT06676488?

The interventions under investigation include: Re-Timer glasses (DEVICE), Placebo Device (DEVICE).

Who is sponsoring clinical trial NCT06676488?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06676488 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritable Bowel Syndrome (IBS)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.